A lump of fatty tissue under your skin caused by repeated injections in the same place.
REPEATED INJECTIONS AT THE SAME SITE CAN LEAD TO:
- Lipohypertrophy
- Cysts
- Scar tissue
THESE ISSUES CAN CAUSE:
- Ineffective and inefficient delivery
- Problems with dosage and absorption, leading to hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose)
ADDITIONAL COSTS FOR PATIENTS DUE TO LIPOHYPERTROPHY MAY INCLUDE:
- Higher insulin doses
- More frequent doctor visits
- Greater expenses for syringes and additional medications
- Increased waste, raising treatment costs
FACTS and opportunities
THE SITUATION TODAY
OPPORTUNITIES IN THE MARKET
THE SITUATION TODAY
- 18.2 Million ER visits by adults with Diabetes in 2021
- $3,100 a day is the average cost for hospital visit
LIFE WITH BULSAI
OPPORTUNITIES IN THE MARKET
THE SITUATION TODAY
- Red Light/Green Light indicator that enablesquick decision-making
- Ensures proper delivery and absorption of insulin
OPPORTUNITIES IN THE MARKET
OPPORTUNITIES IN THE MARKET
OPPORTUNITIES IN THE MARKET
- Insulin delivery devices will make up 49% of the market share for the self-administered home care segment Insulin delivery device market is forecast to grow 8.8% YOY from 2024 – 2033
- 54% increase in the prevalence of diabetes from 2024-2030 in the U.S.